Literature DB >> 19040185

Basic drug information given by physicians is deficient, and patients' knowledge low.

Andreas Storm1, Eva Benfeldt, Stig Ejdrup Andersen, Jørgen Andersen.   

Abstract

OBJECTIVES: Our aim was to assess basic drug information given by physicians when prescribing new topical medication and to compare this with outpatients' subsequent knowledge.
METHODS: Basic drug information was noted during consultations. Subsequently, patients answered a questionnaire regarding diagnosis, treatment, and satisfaction with the consultation. Neither physicians nor patients were informed about the specific study objective.
RESULTS: A total of 17 patients were included. Information provided during the consultations versus patients' knowledge after 2 weeks was: diagnosis (65% vs 41%), dosage by number (100% vs 71%), dosage by quantity (18% vs 12%), and treatment duration (65% vs 35%). None was informed about adverse effects and 47% were fully satisfied with the consultation.
CONCLUSIONS: Basic drug information provided by physicians was deficient and patients' knowledge was even lower.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19040185     DOI: 10.1080/09546630802570818

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  5 in total

1.  Patients' and Doctors' Beliefs about Treatment and Long-Term Adherence in Rheumatic Diseases.

Authors:  John Yfantopoulos; Marianna Protopapa; Konstantinos Mantalias; Athanasios Chantzaras; Katerina Koutsogianni; Platonas Yfantopoulos; Dimitrios Vassilopoulos
Journal:  Mediterr J Rheumatol       Date:  2020-06-11

2.  Pharmacogenetic information for patients on drug labels.

Authors:  Susanne B Haga; Rachel Mills; Jivan Moaddeb
Journal:  Pharmgenomics Pers Med       Date:  2014-10-03

3.  Is the Skin Absorption of Hydrocortisone Modified by the Variability in Dosing Topical Products?

Authors:  Daniel A Paterson; Jacqueline Hallier; Elizabeth Jenkins; Sarah F Cordery; M Begoña Delgado-Charro
Journal:  Pharmaceutics       Date:  2018-01-12       Impact factor: 6.321

4.  Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).

Authors:  Kristian Reich; Ulrich Mrowietz; Eleni Karakasili; Ina Zschocke
Journal:  Arch Dermatol Res       Date:  2014-06-04       Impact factor: 3.017

Review 5.  Barriers to treatment: describing them from a different perspective.

Authors:  Francesca Devine; Taylor Edwards; Steven R Feldman
Journal:  Patient Prefer Adherence       Date:  2018-01-17       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.